XSHE002551
Market cap324mUSD
Jan 10, Last price
2.82CNY
1D
-4.41%
1Q
-1.40%
Jan 2017
-78.22%
IPO
-59.73%
Name
Shenzhen Glory Medical Co Ltd
Chart & Performance
Profile
Shenzhen Glory Medical Co., Ltd. provides hospital construction and medical system integrated solutions in China. The company is involved in the planning, design, management, and implementation of hospital construction projects; installation of medical professional engineering; and medical software development activities. It also sells medical protective equipment, which includes non-woven surgical gowns and medical surgical kits; and medical disposal protective clothing, isolation gowns, and mask, as well as medical surgical consumables. In addition, the company offers medical information solutions, comprising digital operating rooms, surgical teaching systems, remote surgical consultation, mobile digital video station, central management platforms, and digital pre-hospital emergency platforms. Further it provides professional housing and system management, medical equipment maintenance, medical guidance, carer/accompaniment, logistics management, cleaning and greening, security guard, food, and parking lot management services. Shenzhen Glory Medical Co., Ltd. was founded in 1998 and is based in Shenzhen, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,192,887 -6.49% | 1,275,710 -28.74% | |||||||
Cost of revenue | 1,089,415 | 1,166,873 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 103,472 | 108,837 | |||||||
NOPBT Margin | 8.67% | 8.53% | |||||||
Operating Taxes | 33,179 | ||||||||
Tax Rate | 32.07% | ||||||||
NOPAT | 70,293 | 108,837 | |||||||
Net income | (148,889) | ||||||||
Dividends | (58,846) | ||||||||
Dividend yield | 1.72% | ||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 41,460 | ||||||||
Long-term debt | 269,544 | 290,598 | |||||||
Deferred revenue | 80,376 | 84,322 | |||||||
Other long-term liabilities | 4,249 | 3,719 | |||||||
Net debt | (353,921) | (588,087) | |||||||
Cash flow | |||||||||
Cash from operating activities | 17,633 | 96,453 | |||||||
CAPEX | (42,074) | ||||||||
Cash from investing activities | 73,870 | ||||||||
Cash from financing activities | |||||||||
FCF | 156,329 | 179,329 | |||||||
Balance | |||||||||
Cash | 818,199 | 920,145 | |||||||
Long term investments | (194,734) | ||||||||
Excess cash | 563,820 | 856,360 | |||||||
Stockholders' equity | 1,467,731 | 1,665,641 | |||||||
Invested Capital | 2,538,105 | 2,481,840 | |||||||
ROIC | 2.80% | 4.17% | |||||||
ROCE | 3.34% | 3.26% | |||||||
EV | |||||||||
Common stock shares outstanding | 844,809 | 844,758 | |||||||
Price | 4.06 -12.69% | 4.65 -18.28% | |||||||
Market cap | 3,429,926 -12.68% | 3,928,126 -20.61% | |||||||
EV | 3,269,119 | 3,647,470 | |||||||
EBITDA | 199,353 | 233,836 | |||||||
EV/EBITDA | 16.40 | 15.60 | |||||||
Interest | 3,591 | 4,444 | |||||||
Interest/NOPBT | 3.47% | 4.08% |